Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diphtheria-Tetanus-acellular Pertussis Vaccines | 8 | 2022 | 35 | 3.990 |
Why?
|
Immunization Schedule | 15 | 2020 | 221 | 2.950 |
Why?
|
Vaccination | 18 | 2024 | 3321 | 1.900 |
Why?
|
Jaundice, Neonatal | 8 | 2005 | 72 | 1.420 |
Why?
|
Pediatrics | 17 | 2022 | 3573 | 1.370 |
Why?
|
Influenza Vaccines | 9 | 2023 | 764 | 1.340 |
Why?
|
Immunization | 9 | 2019 | 1218 | 1.330 |
Why?
|
Whooping Cough | 6 | 2022 | 81 | 1.280 |
Why?
|
Influenza, Human | 7 | 2023 | 1528 | 1.260 |
Why?
|
Postpartum Period | 7 | 2020 | 1160 | 1.250 |
Why?
|
Immunization Programs | 5 | 2021 | 263 | 1.100 |
Why?
|
Mandatory Programs | 2 | 2021 | 86 | 1.100 |
Why?
|
Child Health Services | 4 | 2020 | 653 | 0.940 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 10 | 2010 | 52 | 0.940 |
Why?
|
Bites and Stings | 7 | 2007 | 93 | 0.840 |
Why?
|
Infant Care | 2 | 2020 | 180 | 0.830 |
Why?
|
Tetanus Toxoid | 5 | 2017 | 192 | 0.790 |
Why?
|
Vaccines, Combined | 5 | 2017 | 70 | 0.780 |
Why?
|
Haemophilus Vaccines | 9 | 2010 | 70 | 0.770 |
Why?
|
Patient Discharge | 5 | 2020 | 3412 | 0.740 |
Why?
|
Oral Health | 3 | 2017 | 477 | 0.730 |
Why?
|
Bacterial Vaccines | 4 | 2019 | 396 | 0.680 |
Why?
|
Chickenpox Vaccine | 7 | 2008 | 41 | 0.630 |
Why?
|
Antibodies, Bacterial | 11 | 2017 | 1455 | 0.610 |
Why?
|
Health Planning Guidelines | 2 | 2009 | 150 | 0.610 |
Why?
|
Haemophilus influenzae type b | 1 | 2017 | 16 | 0.610 |
Why?
|
Coronavirus | 1 | 2020 | 151 | 0.600 |
Why?
|
Anemia, Iron-Deficiency | 3 | 2008 | 366 | 0.570 |
Why?
|
Computer-Assisted Instruction | 2 | 2012 | 360 | 0.570 |
Why?
|
Oseltamivir | 1 | 2016 | 76 | 0.540 |
Why?
|
Reticulocytes | 2 | 2008 | 288 | 0.540 |
Why?
|
Clinical Competence | 6 | 2017 | 4714 | 0.520 |
Why?
|
Poliovirus Vaccine, Inactivated | 3 | 2010 | 24 | 0.510 |
Why?
|
Infant, Newborn | 22 | 2022 | 25914 | 0.500 |
Why?
|
Point-of-Care Systems | 1 | 2024 | 1183 | 0.500 |
Why?
|
Maternal Health Services | 3 | 2012 | 441 | 0.480 |
Why?
|
Health Promotion | 6 | 2017 | 2200 | 0.470 |
Why?
|
Pneumococcal Vaccines | 5 | 2010 | 393 | 0.470 |
Why?
|
Antibody Formation | 4 | 2017 | 1381 | 0.450 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2013 | 109 | 0.440 |
Why?
|
Pandemics | 3 | 2022 | 8505 | 0.410 |
Why?
|
Education, Medical, Continuing | 3 | 2011 | 829 | 0.400 |
Why?
|
Infant | 39 | 2022 | 35673 | 0.390 |
Why?
|
Patient Education as Topic | 4 | 2017 | 2294 | 0.390 |
Why?
|
Meningococcal Vaccines | 5 | 2017 | 95 | 0.380 |
Why?
|
Hemoglobins | 2 | 2008 | 1510 | 0.370 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2022 | 2095 | 0.360 |
Why?
|
Erythrocyte Indices | 2 | 2008 | 146 | 0.360 |
Why?
|
Self Report | 1 | 2021 | 3647 | 0.340 |
Why?
|
New York City | 2 | 2022 | 712 | 0.330 |
Why?
|
Mothers | 3 | 2022 | 2175 | 0.330 |
Why?
|
Child | 27 | 2024 | 78998 | 0.330 |
Why?
|
Pertussis Vaccine | 3 | 2022 | 38 | 0.320 |
Why?
|
Pregnancy | 8 | 2022 | 29439 | 0.320 |
Why?
|
Health Communication | 1 | 2011 | 212 | 0.310 |
Why?
|
Social Marketing | 1 | 2008 | 52 | 0.310 |
Why?
|
Hearing Loss, Conductive | 1 | 2009 | 159 | 0.310 |
Why?
|
Drug Storage | 2 | 2007 | 52 | 0.300 |
Why?
|
Refrigeration | 1 | 2007 | 27 | 0.300 |
Why?
|
Mass Vaccination | 1 | 2009 | 108 | 0.290 |
Why?
|
Hyperbilirubinemia, Neonatal | 1 | 2007 | 28 | 0.290 |
Why?
|
Curriculum | 5 | 2017 | 3653 | 0.290 |
Why?
|
Measles-Mumps-Rubella Vaccine | 2 | 2007 | 72 | 0.280 |
Why?
|
Dogs | 5 | 2007 | 3840 | 0.280 |
Why?
|
Viral Vaccines | 2 | 2007 | 594 | 0.280 |
Why?
|
Bordetella pertussis | 4 | 1995 | 43 | 0.270 |
Why?
|
United States | 19 | 2023 | 71442 | 0.260 |
Why?
|
Pregnant Women | 2 | 2022 | 557 | 0.260 |
Why?
|
Humans | 78 | 2024 | 752341 | 0.260 |
Why?
|
Primary Health Care | 3 | 2020 | 4617 | 0.260 |
Why?
|
Reminder Systems | 2 | 2017 | 385 | 0.250 |
Why?
|
Quality Improvement | 2 | 2019 | 3797 | 0.250 |
Why?
|
Internship and Residency | 6 | 2017 | 5812 | 0.250 |
Why?
|
Child Welfare | 2 | 2008 | 519 | 0.240 |
Why?
|
Health Personnel | 2 | 2010 | 3266 | 0.230 |
Why?
|
Electronic Health Records | 1 | 2021 | 4631 | 0.230 |
Why?
|
Certification | 1 | 2007 | 420 | 0.220 |
Why?
|
Child, Preschool | 23 | 2019 | 41659 | 0.210 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2009 | 781 | 0.210 |
Why?
|
Thermometers | 1 | 2002 | 42 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3066 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3185 | 0.210 |
Why?
|
Vaccines | 2 | 2019 | 829 | 0.190 |
Why?
|
Hepatitis B Vaccines | 3 | 2007 | 183 | 0.190 |
Why?
|
Disease Reservoirs | 1 | 2001 | 121 | 0.190 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2013 | 2466 | 0.190 |
Why?
|
Health Behavior | 1 | 2012 | 2615 | 0.190 |
Why?
|
Vaccines, Conjugate | 6 | 2010 | 326 | 0.180 |
Why?
|
Attitude of Health Personnel | 3 | 2003 | 3821 | 0.180 |
Why?
|
Learning | 2 | 2014 | 1719 | 0.180 |
Why?
|
Hepatitis A Vaccines | 3 | 2006 | 26 | 0.180 |
Why?
|
Fever | 4 | 2007 | 1611 | 0.180 |
Why?
|
Office Visits | 3 | 2017 | 591 | 0.180 |
Why?
|
Antibodies, Viral | 4 | 2010 | 3106 | 0.180 |
Why?
|
Tetanus | 2 | 2017 | 51 | 0.180 |
Why?
|
Health Services Research | 1 | 2008 | 1809 | 0.180 |
Why?
|
Hypercholesterolemia | 1 | 2007 | 1154 | 0.180 |
Why?
|
Female | 34 | 2022 | 386053 | 0.170 |
Why?
|
Haemophilus Infections | 2 | 2017 | 95 | 0.170 |
Why?
|
Cholesterol, LDL | 2 | 2007 | 2407 | 0.170 |
Why?
|
Rotavirus Vaccines | 3 | 2007 | 62 | 0.170 |
Why?
|
Advisory Committees | 4 | 2019 | 781 | 0.170 |
Why?
|
Virus Diseases | 1 | 2005 | 720 | 0.160 |
Why?
|
Mass Screening | 2 | 2007 | 5397 | 0.160 |
Why?
|
Virulence Factors, Bordetella | 2 | 1995 | 154 | 0.160 |
Why?
|
Bilirubin | 3 | 2007 | 436 | 0.160 |
Why?
|
Needs Assessment | 2 | 2004 | 1139 | 0.160 |
Why?
|
Practice Guidelines as Topic | 4 | 2009 | 7399 | 0.160 |
Why?
|
Parents | 2 | 2024 | 3502 | 0.160 |
Why?
|
Health Education | 1 | 2005 | 1048 | 0.160 |
Why?
|
Sudden Infant Death | 1 | 2001 | 296 | 0.150 |
Why?
|
Diphtheria | 1 | 2017 | 33 | 0.150 |
Why?
|
Health Care Surveys | 3 | 2021 | 2427 | 0.150 |
Why?
|
Vaccines, Acellular | 1 | 2017 | 10 | 0.150 |
Why?
|
Program Evaluation | 3 | 2017 | 2464 | 0.140 |
Why?
|
Haemophilus influenzae | 3 | 1993 | 172 | 0.140 |
Why?
|
Logistic Models | 4 | 2021 | 13277 | 0.140 |
Why?
|
Papillomavirus Vaccines | 2 | 2017 | 482 | 0.140 |
Why?
|
Breast Feeding | 2 | 2022 | 1348 | 0.140 |
Why?
|
Nursing Care | 1 | 2017 | 66 | 0.140 |
Why?
|
Polysaccharides, Bacterial | 4 | 2007 | 570 | 0.130 |
Why?
|
Teaching | 3 | 2014 | 1159 | 0.130 |
Why?
|
Viral Hepatitis Vaccines | 2 | 2007 | 75 | 0.130 |
Why?
|
Perception | 1 | 2002 | 1181 | 0.130 |
Why?
|
Education, Medical, Graduate | 1 | 2008 | 2322 | 0.130 |
Why?
|
Cricetulus | 1 | 2017 | 817 | 0.130 |
Why?
|
School Health Services | 2 | 2017 | 382 | 0.130 |
Why?
|
Diphtheria Toxoid | 2 | 1994 | 26 | 0.130 |
Why?
|
Health Status | 2 | 2012 | 4050 | 0.120 |
Why?
|
Hyperbilirubinemia | 2 | 2005 | 75 | 0.120 |
Why?
|
CHO Cells | 1 | 2017 | 1390 | 0.120 |
Why?
|
Prospective Studies | 9 | 2022 | 53807 | 0.120 |
Why?
|
Multivariate Analysis | 3 | 2021 | 12137 | 0.120 |
Why?
|
Guidelines as Topic | 1 | 2001 | 1387 | 0.120 |
Why?
|
Adolescent | 9 | 2021 | 86765 | 0.120 |
Why?
|
New York | 1 | 2017 | 872 | 0.120 |
Why?
|
Chickenpox | 2 | 1997 | 98 | 0.120 |
Why?
|
Clostridium tetani | 2 | 1993 | 5 | 0.110 |
Why?
|
Corynebacterium diphtheriae | 2 | 1993 | 21 | 0.110 |
Why?
|
Decision Making | 1 | 2007 | 3890 | 0.110 |
Why?
|
Animals, Domestic | 2 | 2004 | 57 | 0.110 |
Why?
|
Mumps Vaccine | 2 | 2008 | 16 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2001 | 872 | 0.110 |
Why?
|
Herpesvirus 3, Human | 1 | 1993 | 158 | 0.110 |
Why?
|
Fetal Blood | 2 | 2013 | 1323 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2017 | 3934 | 0.100 |
Why?
|
Child Abuse | 1 | 2001 | 1059 | 0.100 |
Why?
|
Salmonella Infections | 2 | 2005 | 166 | 0.100 |
Why?
|
Medical Order Entry Systems | 1 | 2017 | 516 | 0.100 |
Why?
|
Dental Caries | 1 | 2015 | 421 | 0.090 |
Why?
|
Sampling Studies | 2 | 2002 | 616 | 0.090 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2010 | 33 | 0.090 |
Why?
|
Antigens, Bacterial | 3 | 2002 | 1152 | 0.090 |
Why?
|
Hepatitis A | 2 | 2007 | 133 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2441 | 0.090 |
Why?
|
Measles Vaccine | 2 | 2004 | 79 | 0.090 |
Why?
|
Cats | 2 | 2001 | 968 | 0.080 |
Why?
|
Adult | 12 | 2021 | 216913 | 0.080 |
Why?
|
Otoscopy | 1 | 2009 | 40 | 0.080 |
Why?
|
Male | 22 | 2017 | 354881 | 0.080 |
Why?
|
Universal Precautions | 1 | 2009 | 34 | 0.080 |
Why?
|
Immunity, Herd | 1 | 2009 | 46 | 0.080 |
Why?
|
Caregivers | 1 | 2020 | 2172 | 0.080 |
Why?
|
Hearing Tests | 1 | 2009 | 121 | 0.080 |
Why?
|
Public Health | 1 | 2022 | 2644 | 0.080 |
Why?
|
Audiometry | 1 | 2009 | 253 | 0.080 |
Why?
|
Streptococcal Vaccines | 1 | 2008 | 43 | 0.080 |
Why?
|
Biomedical Research | 1 | 2003 | 3379 | 0.080 |
Why?
|
Polysaccharide-Lyases | 1 | 1987 | 47 | 0.080 |
Why?
|
Heparin Antagonists | 1 | 1987 | 32 | 0.080 |
Why?
|
Random Allocation | 2 | 2002 | 2387 | 0.070 |
Why?
|
Blood Cell Count | 1 | 2008 | 398 | 0.070 |
Why?
|
Meningococcal Infections | 1 | 2007 | 79 | 0.070 |
Why?
|
Drug Stability | 1 | 2007 | 290 | 0.070 |
Why?
|
Bacterial Proteins | 4 | 2002 | 3803 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2002 | 3678 | 0.070 |
Why?
|
Phototherapy | 2 | 2007 | 368 | 0.070 |
Why?
|
Rotavirus Infections | 1 | 2007 | 86 | 0.070 |
Why?
|
Freezing | 1 | 2007 | 299 | 0.070 |
Why?
|
Ethics Committees, Research | 1 | 2008 | 195 | 0.070 |
Why?
|
ROC Curve | 2 | 2005 | 3530 | 0.070 |
Why?
|
Double-Blind Method | 7 | 2007 | 12326 | 0.070 |
Why?
|
Young Adult | 3 | 2021 | 57629 | 0.070 |
Why?
|
Snakes | 1 | 2005 | 29 | 0.060 |
Why?
|
Toxoids | 2 | 1995 | 12 | 0.060 |
Why?
|
Health Status Disparities | 1 | 2017 | 1775 | 0.060 |
Why?
|
Specialty Boards | 1 | 2007 | 228 | 0.060 |
Why?
|
Medication Adherence | 1 | 2017 | 2134 | 0.060 |
Why?
|
Rabies | 1 | 2005 | 54 | 0.060 |
Why?
|
Perinatal Care | 1 | 2007 | 239 | 0.060 |
Why?
|
Markov Chains | 1 | 2008 | 968 | 0.060 |
Why?
|
Hemagglutinins | 2 | 1995 | 113 | 0.060 |
Why?
|
Neonatal Screening | 1 | 2009 | 591 | 0.060 |
Why?
|
Adhesins, Bacterial | 2 | 1995 | 118 | 0.060 |
Why?
|
Salmonella Infections, Animal | 1 | 2004 | 61 | 0.060 |
Why?
|
Animals | 9 | 2017 | 166802 | 0.060 |
Why?
|
Antiviral Agents | 1 | 2016 | 3032 | 0.060 |
Why?
|
Sex Distribution | 1 | 2009 | 2290 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2022 | 79127 | 0.060 |
Why?
|
Vaccines, Synthetic | 4 | 2002 | 614 | 0.060 |
Why?
|
Education, Continuing | 1 | 2004 | 112 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3203 | 0.060 |
Why?
|
Age Distribution | 1 | 2009 | 2883 | 0.050 |
Why?
|
Fasting | 2 | 2007 | 1590 | 0.050 |
Why?
|
Epidemiologic Methods | 1 | 2008 | 1342 | 0.050 |
Why?
|
Lipid A | 1 | 2002 | 69 | 0.050 |
Why?
|
Nurseries, Hospital | 1 | 2002 | 17 | 0.050 |
Why?
|
Ferritins | 1 | 2005 | 595 | 0.050 |
Why?
|
Linear Models | 1 | 2012 | 5858 | 0.050 |
Why?
|
Education, Medical | 1 | 2014 | 1713 | 0.050 |
Why?
|
Risk Assessment | 3 | 2015 | 23783 | 0.050 |
Why?
|
Bacterial Outer Membrane Proteins | 2 | 1995 | 405 | 0.050 |
Why?
|
Vaccines, Inactivated | 2 | 2006 | 181 | 0.050 |
Why?
|
Hearing Loss | 1 | 2009 | 768 | 0.050 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2002 | 174 | 0.050 |
Why?
|
Vaccines, Attenuated | 2 | 2012 | 312 | 0.050 |
Why?
|
Cross Infection | 1 | 2010 | 1426 | 0.050 |
Why?
|
Cost-Benefit Analysis | 3 | 2012 | 5481 | 0.050 |
Why?
|
Gilbert Disease | 1 | 2000 | 4 | 0.050 |
Why?
|
Poliovirus Vaccines | 1 | 2000 | 14 | 0.050 |
Why?
|
Algorithms | 1 | 2001 | 13900 | 0.050 |
Why?
|
Bacterial Capsules | 4 | 2007 | 242 | 0.040 |
Why?
|
Health Policy | 2 | 2012 | 2656 | 0.040 |
Why?
|
Heparin | 1 | 1987 | 1645 | 0.040 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2002 | 430 | 0.040 |
Why?
|
Maternal Age | 1 | 2002 | 800 | 0.040 |
Why?
|
Accreditation | 1 | 2002 | 464 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2005 | 14586 | 0.040 |
Why?
|
Education, Medical, Undergraduate | 1 | 2008 | 1049 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10198 | 0.040 |
Why?
|
Cost of Illness | 1 | 2008 | 1912 | 0.040 |
Why?
|
Maternal Welfare | 1 | 1999 | 112 | 0.040 |
Why?
|
Data Collection | 1 | 2008 | 3302 | 0.040 |
Why?
|
Renal Dialysis | 1 | 1987 | 1735 | 0.040 |
Why?
|
Educational Measurement | 1 | 2005 | 1244 | 0.040 |
Why?
|
Rabbits | 1 | 2004 | 4761 | 0.040 |
Why?
|
Complementary Therapies | 1 | 2002 | 485 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 25535 | 0.040 |
Why?
|
Cohort Studies | 2 | 2012 | 40984 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2002 | 972 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2002 | 1024 | 0.040 |
Why?
|
Physicians, Women | 1 | 2002 | 485 | 0.030 |
Why?
|
Gestational Age | 1 | 2005 | 3546 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 21841 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2004 | 6234 | 0.030 |
Why?
|
Medication Errors | 1 | 2001 | 773 | 0.030 |
Why?
|
Societies, Medical | 1 | 2007 | 3833 | 0.030 |
Why?
|
Medical Records Systems, Computerized | 1 | 2001 | 1190 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2000 | 782 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2001 | 3463 | 0.030 |
Why?
|
Rubella Vaccine | 1 | 1993 | 22 | 0.030 |
Why?
|
Poliovirus Vaccine, Oral | 1 | 1993 | 26 | 0.030 |
Why?
|
Central Nervous System Stimulants | 1 | 2002 | 1161 | 0.030 |
Why?
|
Pneumonia | 1 | 2004 | 2121 | 0.030 |
Why?
|
Staff Development | 1 | 2014 | 229 | 0.030 |
Why?
|
Latex Fixation Tests | 1 | 1991 | 29 | 0.020 |
Why?
|
Immunization, Secondary | 1 | 1994 | 357 | 0.020 |
Why?
|
Drugs, Investigational | 1 | 1993 | 213 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 1999 | 1391 | 0.020 |
Why?
|
Incidence | 1 | 2009 | 21158 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2009 | 39079 | 0.020 |
Why?
|
Family | 1 | 2001 | 3165 | 0.020 |
Why?
|
Internet | 1 | 2002 | 3064 | 0.020 |
Why?
|
Attitude | 1 | 2014 | 772 | 0.020 |
Why?
|
Physicians | 1 | 2007 | 4550 | 0.020 |
Why?
|
Length of Stay | 1 | 2002 | 6372 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 1993 | 1519 | 0.020 |
Why?
|
Sex Factors | 1 | 2002 | 10455 | 0.020 |
Why?
|
Massachusetts | 1 | 2001 | 8707 | 0.020 |
Why?
|
Flavobacterium | 1 | 1987 | 20 | 0.020 |
Why?
|
Heparin Lyase | 1 | 1987 | 36 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2002 | 19894 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1487 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2012 | 795 | 0.020 |
Why?
|
Immunoglobulin G | 2 | 2002 | 4518 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2002 | 12898 | 0.020 |
Why?
|
Hematologic Tests | 1 | 1987 | 236 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2002 | 7995 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2012 | 917 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2012 | 1708 | 0.020 |
Why?
|
Prevalence | 1 | 2002 | 15506 | 0.020 |
Why?
|
Registries | 1 | 2001 | 8362 | 0.020 |
Why?
|
Sheep | 1 | 1987 | 1437 | 0.020 |
Why?
|
Diet | 1 | 2002 | 7949 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2007 | 1572 | 0.010 |
Why?
|
Aluminum Compounds | 1 | 2002 | 53 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3678 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2009 | 64245 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2007 | 2937 | 0.010 |
Why?
|
Immunity | 1 | 2007 | 993 | 0.010 |
Why?
|
Autoanalysis | 1 | 2000 | 71 | 0.010 |
Why?
|
Surface-Active Agents | 1 | 2000 | 149 | 0.010 |
Why?
|
Equipment Design | 1 | 1987 | 3510 | 0.010 |
Why?
|
Phosphates | 1 | 2002 | 765 | 0.010 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2000 | 237 | 0.010 |
Why?
|
Communication | 1 | 2012 | 3805 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2002 | 1538 | 0.010 |
Why?
|
Boston | 2 | 2000 | 9236 | 0.010 |
Why?
|
Heating | 1 | 1997 | 101 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 1996 | 554 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2002 | 1788 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 1996 | 676 | 0.010 |
Why?
|
Rubella virus | 1 | 1993 | 11 | 0.010 |
Why?
|
Risk Factors | 1 | 2001 | 73412 | 0.010 |
Why?
|
Mumps virus | 1 | 1993 | 23 | 0.010 |
Why?
|
Measles virus | 1 | 1993 | 66 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 2000 | 1815 | 0.010 |
Why?
|
Eating | 1 | 2000 | 1537 | 0.010 |
Why?
|
Poliovirus | 1 | 1993 | 106 | 0.010 |
Why?
|
Anorexia | 1 | 1993 | 154 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1994 | 641 | 0.010 |
Why?
|
Reference Values | 1 | 2000 | 4897 | 0.010 |
Why?
|
Time Factors | 2 | 1991 | 39854 | 0.010 |
Why?
|
Irritable Mood | 1 | 1993 | 182 | 0.010 |
Why?
|
Triglycerides | 1 | 2000 | 2469 | 0.010 |
Why?
|
Erythema | 1 | 1993 | 261 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2002 | 5412 | 0.010 |
Why?
|
Japan | 1 | 1996 | 1333 | 0.010 |
Why?
|
Cholesterol | 1 | 2000 | 2904 | 0.010 |
Why?
|
Regression Analysis | 1 | 2000 | 6360 | 0.010 |
Why?
|
Sleep Stages | 1 | 1993 | 674 | 0.010 |
Why?
|
Safety | 1 | 1993 | 1146 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 1987 | 17958 | 0.000 |
Why?
|
Antigens | 1 | 1993 | 1439 | 0.000 |
Why?
|
Drug Monitoring | 1 | 1994 | 959 | 0.000 |
Why?
|
Cytokines | 1 | 2002 | 7235 | 0.000 |
Why?
|
Drug Combinations | 1 | 1993 | 1998 | 0.000 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1993 | 3781 | 0.000 |
Why?
|
Immunologic Memory | 1 | 1991 | 1324 | 0.000 |
Why?
|
Age Factors | 1 | 1993 | 18297 | 0.000 |
Why?
|